Company Description
Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The company’s initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options.
Significant Investors
Westlake Village BioPartners, Surveyor Capital, Logos Capital, RA Capital Management, 5AM Ventures, Kleiner Perkins, Sanofi Ventures, Novartis Venture Fund
